Catalyst Wire Dossier Catalyst Wire Dossier

MSRD-100

· Merz North America, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MSRD-100, covering 2016-09-09 to 2016-09-09. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety Study of MSRD-100 in Subjects With Atopic Dermatitis >=3 Months of Age and Older [Phase 3]

See pricing